The Cancer Center for Cancer Research, NCI, and the Chemistry and Structural Biology Faculty are pleased to announce "Chemical Insights Into Biological Processes." The symposium will bring together leaders in the rapidly emerging field of chemical biology to discuss cutting-edge approaches to a broad range of problems in cancer and other diseases.
For more information and to register, visit http://web.ncifcrf.gov/events/ccrcbs/2008.
The program will include:
- Gregory L. Verdine, Ph.D., Harvard University, Cancer Chemical Biology
- Carolyn Bertozzi, Ph.D., University of California, Berkeley, Imaging the Glycome
- Benjamin F. Cravatt III, Ph.D., Skaggs Institute/Scripps, Mapping Pathways in Human Disease by Activity-Based Proteomics & Metabolomics
- Jon Clardy, Ph.D., Harvard Medical School, Ecological Insights into Small Molecule Discovery, Biosynthesis, and Evolution
- Peter Schultz, Ph.D., Scripps Research Institute, Synthesis at the Interface of Chemistry and Biology
- Craig Thomas, Ph.D., Chemical Genomics Center, NIH, Integrating Chemistry with Biology at the NIH: Big Challenges and Bigger Opportunities
- Angela Belcher, Ph.D., MIT, From Nature & Back Again: Giving New life to Materials for Energy, Environment & Medicine
- James R. Heath, Ph.D., California Institute of Technology, Systems Biology-Driven Technologies for In Vitro Diagnosis & Analysis of Cancer
- Laura L. Kiessling, Ph.D., University of Wisconsin-Madison, Low-Affinity Interactions for High-Specificity Tumor Cell Targeting
- Lawrence Marnett, Ph.D., Vanderbilt Institute of Chemical Biology, Targeting Cyclooxygenase-2 for Cancer Imaging and Therapeutics
- Milan Mrksich, Ph.D., University of Chicago, BioChips Without the Labels: Applications to Histone Modification
- Amy Jacobs, Ph.D., CCR Nanobiology Program, Probing Conformational Changes in Membrane Proteins During Membrane Fusion
- Alanna Schepartz, Ph.D., Yale University, Imaging Protein Assembly and Trafficking in Live Cells Without Fluorescent Proteins
- Mike E. Jung, Ph.D., University of California, Los Angeles, Rational Drug Design for the Treatment of Hormone-Refractory Prostate Cancer
- Cynthia J. Burrows, Ph.D., University of Utah, Chemistry and Biology of Oxidative DNA Damage
- Elio Abbondanzieri, Ph.D., Harvard University, Molecular Gymnastics: Dynamic Binding Orientations of HIV Reverse Transcriptase
- Moungi G. Bawendi, Ph.D., Massachusetts Institute of Technology, Designing Quantum Dots for Biological and Biomedical Imaging
- Yves Pommier, Ph.D., Chief, Laboratory of Molecular Pharmacology, CCR, Non-Camptothecin Topoisomerase I Inhibitors: a 10 Year Odyssey
Individuals with disabilities who need Sign Language Interpreters and/or reasonable accommodation to participate in this program should contact Karen Kochersberger, SAIC-Frederick, Inc. (301) 228-4027 and/or the Federal Relay (1-800-877-8339). Requests should be made at least 5 days in advance of the event.